Stocksigma LogoStocksigma Logo

Sheel Biotech Full IPO Proceeds Utilization and Monitoring Qualification

CARE Ratings issued its final monitoring agency report for Sheel Biotech Limited for the period ended 30th Sep'26, confirming total IPO proceeds of ₹34.02

Sheel Biotech Full IPO Proceeds Utilization and Monitoring Qualification

Sheel Biotech Ltd · Others (Uncategorized) · 13 Nov 2026, 10:24 pm

Sheel Biotech Full IPO Proceeds Utilization and Monitoring Qualification CARE Ratings issued its final monitoring agency report for Sheel Biotech Limited for the period ended 30th Sep'26, confirming total IPO proceeds of ₹34.02 crore have been fully utilized. The agency qualified its report due to unauthorized deviations: ₹2.66 crore was deployed for land purchases in Satara, Maharashtra, instead of the offer document's Ghaziabad location without shareholder approval. Additionally, the company changed capex vendors without specified mechanisms and lacked supporting invoices for ₹2.58 crore in general corporate payments, relying on auditor certificates.

Original exchange filing (PDF)

More announcements from Sheel Biotech Ltd

All Sheel Biotech Ltd announcements